Single-Use Bioreactors Market in terms of revenue was estimated to be worth $4.2 billion in 2023 and is poised to reach $10.0 billion by 2028, growing at a CAGR of 19.0% from 2023 to 2028 according to a new report by MarketsandMarkets™.

Request for FREE Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=49113750

Factors such as the increasing adoption of single-use bioreactors among startups and SMEs, lower operational complexity of single-use bioreactors compared to conventional stainless-steel bioreactors, reduced energy and water consumption, growing size of the biologics and biosimilars market, and technological advancements in single-use bioreactors.

Browse in-depth TOC on "Single-Use Bioreactors Market"

408 - Tables

48 - Figures

345 – Pages

TOP Single-Use Bioreactors MARKET PLAYER

The single-use bioprocessing market is highly consolidated with majority of the market share taken up by key players such as Thermo Fisher Scientific (US), Danaher Corporation (US), Sartorius Stedim Biotech S.A. (France), and Merck KGaA (Germany). The key players in this market are increasingly focusing on strategic expansions, partnerships, and product approvals to expand their manufacturing capabilities and increase market presence.

Sartorius Stedim Biotech held the leading position in the single-use bioprocessing market. Sartorius focuses on strengthening its position in the market by adopting organic and inorganic strategies such as product launches and expansions. During the past three years, Sartorius Stedim Biotech launched SUB systems such as BIOSTAT STR Generation 3 Single-Use Bioreactor, BIOSTAT RM TX Single-Use Bioreactor, and BIOSTAT STR. Sartorius acquired Danaher’s Life Science portfolio, which is complementary to the portfolio of Sartorius’s laboratory and bioprocess business. the company also expanded their operations in Puerto Rico.

Thermo Fisher Scientific is the second-largest player in the single-use bioprocessing market. Thermo Fisher Scientific operates in the single-use bioprocessing market through the life science solutions business segment. To further increase its share in the single-use bioprocessing market, the company focuses on growth strategies such as acquisitions and expansion. the company expanded its business in the US. The company also made investments worth ~USD 650 million to enhance their single-use bioprocessing capabilities and increase their market share.

The Asia Pacific region is the fastest-growing region of the single-use bioreactors market.

Based on the region, the single-use bioreactors market is segmented into five major regions: North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. The Asia Pacific market is expected to register the highest CAGR during the forecast period. Factors such as the growing biopharmaceutical industry, rising investments by pharmaceutical & biotechnology companies, and the growing number of CROs & CMOs in several Asia Pacific countries are supporting the growth of the market in the region.

Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=49113750